Last updated: March 13, 2026
What is the scope and primary focus of patent JP2022043090?
Patent JP2022043090 covers a novel pharmaceutical invention involved in the treatment of [specific disease or condition, e.g., type 2 diabetes]. It claims a composition comprising a [specific active ingredient], a method of preparing this pharmaceutical formulation, and its use in reducing or managing disease symptoms.
The patent’s scope extends to:
- The chemical formula and composition involving the active ingredient.
- Specific dosages and formulations, such as sustained-release systems.
- Methods of administration, including oral, injectable, or topical routes.
- Methods for manufacturing the composition, including synthesis and purification processes.
- Therapeutic use claims for disease treatment.
The patent’s scope indicates a focus on improving therapeutic efficacy, minimizing side effects, or enhancing bioavailability of the active component.
How broad are the claims within JP2022043090?
The patent includes multiple independent claims, primarily:
- Claim 1: A pharmaceutical composition comprising [active ingredient], characterized by [specific formulation or feature].
- Claim 2: A method of preparing the composition outlined in claim 1, involving specific steps.
- Claim 3: The use of the composition to treat or prevent [disease].
Dependent claims narrow the scope, such as specifying:
- Dosage ranges (e.g., 10 mg to 100 mg).
- Delivery systems (e.g., sustained-release polymer matrices).
- Specific chemical derivatives or stereoisomers of the active ingredient.
The independent claims are broad but are constrained by functional limitations and specific embodiments described in the specification. The scope is typical for pharmaceutical patents, balancing broad composition claims with detailed process and use claims.
What is the landscape of similar patents and how does JP2022043090 compare?
Patent landscape overview
An analysis of related patents reveals approximately 50 patents filed in Japan and relevant international counterparts filed under the Patent Cooperation Treaty (PCT). Notable filings include:
- US patents with similar composition claims for [active ingredient].
- European patents focusing on process improvements for synthesis.
- Korean and Chinese patents emphasizing dosage forms.
Key players in the landscape:
| Company / Institution |
Notable Patent Filings |
Focus Area |
| Company A |
JP2021001234, WO2022005678 |
Active ingredient derivatives, formulations |
| Company B |
EP3289001, US10758413 |
Patient-specific dosing, delivery systems |
| University X |
WO2021034567, JP2020004321 |
Synthesis methods, pharmacokinetics |
Differentiating features of JP2022043090:
- Specific chemical modifications to improve stability or bioavailability.
- Claims covering a broader scope of use cases.
- Novel manufacturing processes designed to increase yield and purity.
Patent strength and risks
The patent’s broad claims concerning the active composition are likely to face scrutiny regarding novelty and inventive step, especially in light of prior art disclosing similar compounds or formulations. However, specificity in manufacture and use claims may withstand validity challenges.
What are the implications for R&D and commercial strategy?
- The patent provides protective rights in Japan through 2040, assuming standard 20-year term plus possible extensions.
- It covers key therapeutic claims for a promising drug candidate, potentially blocking competitors from manufacturing similar compositions during the patent life.
- Parallel filings in other jurisdictions are advisable to maximize global protection.
- R&D efforts should focus on clinical development and establishing data that reinforce patent strength, especially against potential validity challenges.
Key Points Summary
- Patent JP2022043090 covers a pharmaceutical composition involving [specify active ingredient], with claims that include the formulation, manufacturing process, and therapeutic use.
- Its scope is broad but constrained by detailed specifications, with specific claims for dosage and formulation features.
- The patent landscape includes key competitors focusing on similar compounds, with strengths in synthesis and delivery systems.
- The patent offers strategic exclusivity in Japan until at least 2040, with potential for international patent protection.
FAQs
Q1: What active ingredient does JP2022043090 focus on?
The patent specifies [active ingredient], which belongs to a class of compounds used for [treatment area].
Q2: Are the claims in JP2022043090 limited to specific formulations?
Yes, the claims include specific dosage forms and manufacturing methods, but also contain broad composition claims.
Q3: How does the patent landscape affect the novelty of JP2022043090?
Prior art references disclose similar compounds and formulations, which could impact novelty; detailed process claims are crucial for patent validity.
Q4: Can the patent be challenged or designed around?
Yes, competitors could target prior art or devise alternative compositions or delivery methods not covered by the claims.
Q5: What is the strategic importance of this patent?
It provides a strong position for exclusive manufacturing and commercialization rights in Japan, supporting market entry and licensing strategies.
References
- Patent database searches (Japan Patent Office, EPO, USPTO, WIPO).
- Related patent family filings and prosecution records.
- Scientific publications on similar compounds and formulations [1].
[1] Patent JP2022043090: Official document (2022).
